Cannabis Stocks To Add to Your Watchlist - September 5th

Key Points

• Tilray Brands, Canopy Growth, and five other companies are highlighted as key cannabis stocks to monitor, reflecting their significant trading volume and involvement in the growing legal cannabis market.
• Cannabis stocks carry high volatility and regulatory risks, making them attractive yet challenging investments within the medical, recreational, and ancillary sectors of the cannabis industry.
• Incannex Healthcare specializes in developing medicinal cannabinoid and psychedelic products for various health issues, showcasing the expanding scope of cannabis applications in pharmaceuticals.

Tilray Brands, Canopy Growth, Incannex Healthcare, Indivior, Turning Point Brands, Innovative Industrial Properties, and SNDL are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies involved in the cultivation, production, distribution or sale of cannabis and related products. Investing in these stocks provides exposure to the rapidly growing legal cannabis market—spanning medical, recreational and ancillary services—but they often carry elevated volatility and regulatory risk. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Tilray Brands (TLRY)

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Read Our Latest Research Report on TLRY

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Read Our Latest Research Report on CGC

Incannex Healthcare (IXHL)

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.

Read Our Latest Research Report on IXHL

Indivior (INDV)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Read Our Latest Research Report on INDV

Turning Point Brands (TPB)

Turning Point Brands, Inc., together with its subsidiaries, manufactures, markets, and distributes branded consumer products. The company operates through three segments: Zig-Zag Products, Stoker's Products, and Creative Distribution Solutions. Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, make-your-own cigar wraps, and related products, as well as lighters and other accessories under the Zig-Zag brand.

Read Our Latest Research Report on TPB

Innovative Industrial Properties (IIPR)

Read Our Latest Research Report on IIPR

SNDL (SNDL)

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores.

Read Our Latest Research Report on SNDL

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.